Recently, there has been a growing awareness of the multiple interrelationships between depression and various physical diseases. Patients with psychiatric problems, particularly depression, may be more susceptible to cardiovascular disorders. Depression and Heart Disease synthesizes current evidence, including some previously unpublished data, in a concise, easy-to-read format. The authors succinctly describe the epidemiology, pathogenesis (including cytokines and genetics), and risk factors of the comorbidity between depression and heart disease. The book also reviews the best pharmacological and psychotherapeutic approaches for people with this comorbidity.
表中的内容
CHAPTER 1 Epidemiology of the comorbidity between depression and
heart disease
Wei Jiang, Glen L. Xiong
CHAPTER 2 The association between depression and heart disease:
the role of biological mechanisms
Palmiero Monteleone
CHAPTER 3 The association between depression and heart disease:
the role of genetic factors
Eco de Geus
CHAPTER 4 Behavioral and psychological mechanisms linking
depression and heart disease
Roy C. Ziegelstein, Mary Kate Elfrey
CHAPTER 5 Depression and cardiovascular disease: the safety of
antidepressant drugs and the ability to improve mood and reduce
medical morbidity
Alexander H. Glassman, J. Thomas Bigger, Jr
CHAPTER 6 Psychotherapies for depression in people with heart
disease
Robert M. Carney, Kenneth E. Freedland
关于作者
Alexander Glassman is an authority on depression and
antidepressant drugs, who has raised the standard of care for
depressed patients. His work has clarified the safe treatment of
depressed patients with cardiovascular disease: more
recently, he has been involved in studies of the relationship
between depression and cardiovascular mortality. Dr. Glassman
was the recipient of the American Psychiatric Association’s
Foundation Fund Prize for lifetime accomplishment in Research, the
Established Investigator’s Award of the National Association for
Research in Schizophrenia and Affective Disorders, the New York
State Research Award and the 2007-2008 Anna-Monika Foundation Prize
for reseach in depression. He is the author of over 300 scientific
publications and serves on the editorial boards of Heart
Disease and the Journal of Clinical Psychopharmacology.
He is a fellow of the American College of Neuropsychopharmacology,
a life fellow of the American Psychiatric Association, a member of
the scientific advisory board of the National Alliance for Research
on Schizophrenia and Depression (NARSAD), and a member of the
scientific advisory panel of the American Legacy Panel.
Mario Maj is Professor of Psychiatry and Chairman at the
University of Naples, Italy. He is President of the World
Psychiatric Association and former President of the European
Psychiatric Association. He is the Italian psychiatrist with the
highest number of citations in indexed journals in the period
1981-2008.
Norman Sartorius is President of the International
Association for the Promotion of Mental Health Programmes.
Honorary Fellow of the Royal College of Psychiatrists of the United
Kingdom of Great Britain, of the Royal Australian and New Zealand
College of Psychiatrists and of the American College of Psychiatry;
Distinguished Fellow of the American Psychiatric Association.
Member of the WHO Expert Advisory Panel on Mental Health.
Member of WPA Council.